Related Experiment Video
Updated: Mar 17, 2026
Bioluminescence Imaging of NADPH Oxidase Activity in Different Animal Models
Published on: October 22, 2012
Functional Heterogeneity of Nadph Oxidases in Atherosclerotic and Aneurysmal Diseases
Yasuyoshi Kigawa1, Takuro Miyazaki, Xiao-Feng Lei
1Division of Endocrinology and Metabolism, Showa University Fujigaoka Hospital.
Abstract:
NADPH oxidases (NOX) are enzymes that catalyze the production of reactive oxygen species (ROS). Four species of NOX catalytic homologs (NOX1, NOX2, NOX4, and NOX5) are reportedly expressed in vascular tissues. The pro-atherogenic roles of NOX1, NOX2, and their organizer protein p47ph°x were manifested, and it was noted that the hydrogen peroxide-generating enzyme NOX4 possesses atheroprotective effects. Loss of NOX1 or p47ph°x appears to ameliorate murine aortic dissection and subsequent aneurysmal diseases; in contrast, the ablation of NOX2 exacerbates the aneurysmal diseases. It is possible that the loss of NOX2 activates inflammatory cascades in macrophages in the lesions. Roles of NOX5 in vascular functions are currently undetermined, owing to the absence of this enzyme in rodents and the limitation of the experimental procedure. Thus, it is possible that the NOX family of enzymes exhibits heterogeneity in the atherosclerotic diseases. In this aspect, subtype-selective NOX inhibitor may be promising when NOX systems serve as a molecular target for atherosclerotic and aneurysmal diseases.
Insights
NADPH oxidases (NOX) enzymes have varied roles in vascular diseases. While NOX1 and NOX2 promote atherosclerosis, NOX4 is protective, suggesting targeted NOX inhibition for treating vascular conditions.
Area of Science:
- Biochemistry
- Cardiovascular Biology
- Molecular Medicine
Background:
- NADPH oxidases (NOX) are key enzymes regulating reactive oxygen species (ROS) production.
- Four NOX homologs (NOX1, NOX2, NOX4, NOX5) are expressed in vascular tissues, with distinct roles.
- NOX1, NOX2, and p47phox are implicated in pro-atherogenic processes, while NOX4 exhibits atheroprotective effects.
Purpose of the Study:
- To investigate the heterogeneous roles of NADPH oxidase (NOX) enzymes in vascular diseases.
- To elucidate the specific contributions of NOX1, NOX2, NOX4, and NOX5 in atherosclerosis and aortic diseases.
- To explore the therapeutic potential of subtype-selective NOX inhibitors.
Main Methods:
- Analysis of existing literature on NOX enzyme expression and function in vascular tissues.
- Review of studies examining the effects of NOX1, NOX2, and p47phox ablation on murine aortic dissection and aneurysmal diseases.
- Consideration of the challenges in studying NOX5 due to its absence in rodents.
Main Results:
- Loss of NOX1 or p47phox ameliorates murine aortic dissection and aneurysmal diseases.
- Ablation of NOX2 exacerbates aneurysmal diseases, potentially by activating macrophage inflammatory cascades.
- NOX4 demonstrates atheroprotective effects by generating hydrogen peroxide.
Conclusions:
- The NOX enzyme family exhibits functional heterogeneity in the context of atherosclerotic and aneurysmal diseases.
- NOX1, NOX2, and NOX4 play differential roles, with NOX1/NOX2 being pro-atherogenic and NOX4 being atheroprotective.
- Targeting specific NOX subtypes with inhibitors offers a promising therapeutic strategy for vascular diseases.
Related Concept Videos
01:26Coronary Artery Disease II: Pathophysiology
01:30Atherosclerosis I: Introduction
01:30Peripheral Artery Disease I: Introduction
01:24Peroxisomes